A type of genetic abnormality linked to cancer is more common in people with type 2 diabetes than the rest of the population, a new study has found.
Clonal mosaic events (CMEs) are defects that result in some cells having extra copies or missing copies of large chunks of DNA. It has been found that people with CMEs have a tenfold risk of blood cancers.
Researchers looked for CMEs in blood samples from 7,437 participants in genetic studies in Europe, including 2,208 people with type 2 diabetes. They found that CMEs were four times more common in people with Type 2 diabetes.
Read more at Imperial College London and CNRS in France